Bzdyl N, Moran C, Bendo J, Sarkar-Tyson M
Virulence. 2022; 13(1):1945-1965.
PMID: 36271712
PMC: 9635556.
DOI: 10.1080/21505594.2022.2139063.
Meng S, Lakshika Hettiarachchi I, Bhetuwal B, Thapa P, Zhu J
J Org Chem. 2022; 87(10):6588-6600.
PMID: 35537215
PMC: 9166265.
DOI: 10.1021/acs.joc.2c00168.
Chomkatekaew C, Boonklang P, Sangphukieo A, Chewapreecha C
Front Microbiol. 2021; 11:612568.
PMID: 33552023
PMC: 7858667.
DOI: 10.3389/fmicb.2020.612568.
Shneider M, Lukianova A, Evseev P, Shpirt A, Kabilov M, Tokmakova A
Int J Mol Sci. 2020; 21(9).
PMID: 32365879
PMC: 7246868.
DOI: 10.3390/ijms21093170.
Lukianova A, Shneider M, Evseev P, Shpirt A, Bugaeva E, Kabanova A
Front Microbiol. 2020; 10:3147.
PMID: 32038580
PMC: 6989608.
DOI: 10.3389/fmicb.2019.03147.
Potential targets for next generation antimicrobial glycoconjugate vaccines.
Micoli F, Costantino P, Adamo R
FEMS Microbiol Rev. 2018; 42(3):388-423.
PMID: 29547971
PMC: 5995208.
DOI: 10.1093/femsre/fuy011.
Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.
Tamigney Kenfack M, Mazur M, Nualnoi T, Shaffer T, Ngassimou A, Bleriot Y
Nat Commun. 2017; 8(1):115.
PMID: 28740137
PMC: 5524647.
DOI: 10.1038/s41467-017-00173-8.
Secondary metabolites from Bacillus amyloliquefaciens isolated from soil can kill Burkholderia pseudomallei.
Boottanun P, Potisap C, Hurdle J, Sermswan R
AMB Express. 2017; 7(1):16.
PMID: 28050857
PMC: 5209304.
DOI: 10.1186/s13568-016-0302-0.
Protection against Experimental Melioidosis with a Synthetic manno-Heptopyranose Hexasaccharide Glycoconjugate.
Scott A, Christ W, George A, Stokes M, Lohman G, Guo Y
Bioconjug Chem. 2016; 27(6):1435-46.
PMID: 27124182
PMC: 4911622.
DOI: 10.1021/acs.bioconjchem.5b00525.
Colony morphology variation of Burkholderia pseudomallei is associated with antigenic variation and O-polysaccharide modification.
Wikraiphat C, Saiprom N, Tandhavanant S, Heiss C, Azadi P, Wongsuvan G
Infect Immun. 2015; 83(5):2127-38.
PMID: 25776750
PMC: 4399047.
DOI: 10.1128/IAI.02785-14.
Production of a recombinant vaccine candidate against Burkholderia pseudomallei exploiting the bacterial N-glycosylation machinery.
Garcia-Quintanilla F, Iwashkiw J, Price N, Stratilo C, Feldman M
Front Microbiol. 2014; 5:381.
PMID: 25120536
PMC: 4114197.
DOI: 10.3389/fmicb.2014.00381.
Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate.
Scott A, Ngugi S, Laws T, Corser D, Lonsdale C, DElia R
J Immunol Res. 2014; 2014:392170.
PMID: 24892035
PMC: 4033506.
DOI: 10.1155/2014/392170.
Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
Lafontaine E, Zimmerman S, Shaffer T, Michel F, Gao X, Hogan R
PLoS One. 2013; 8(10):e76804.
PMID: 24098563
PMC: 3788738.
DOI: 10.1371/journal.pone.0076804.
Structural and immunochemical studies of the lipopolysaccharide from the fish pathogen, Aeromonas bestiarum strain K296, serotype O18.
Turska-Szewczuk A, Lindner B, Komaniecka I, Kozinska A, Pekala A, Choma A
Mar Drugs. 2013; 11(4):1235-55.
PMID: 23595053
PMC: 3705401.
DOI: 10.3390/md11041235.
Detection of Burkholderia pseudomallei O-antigen serotypes in near-neighbor species.
Stone J, Mayo M, Grasso S, Ginther J, Warrington S, Allender C
BMC Microbiol. 2012; 12:250.
PMID: 23126230
PMC: 3541218.
DOI: 10.1186/1471-2180-12-250.
Detailed structural analysis of the O-polysaccharide expressed by Burkholderia thailandensis E264.
Heiss C, Burtnick M, Black I, Azadi P, Brett P
Carbohydr Res. 2012; 363:23-8.
PMID: 23103510
PMC: 3496072.
DOI: 10.1016/j.carres.2012.09.027.
Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.
AuCoin D, Reed D, Marlenee N, Bowen R, Thorkildson P, Judy B
PLoS One. 2012; 7(4):e35386.
PMID: 22530013
PMC: 3328442.
DOI: 10.1371/journal.pone.0035386.
Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.
Cuccui J, Milne T, Harmer N, George A, Harding S, Dean R
Infect Immun. 2012; 80(3):1209-21.
PMID: 22252864
PMC: 3294636.
DOI: 10.1128/IAI.05805-11.
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
Bondi S, Goldberg J
Expert Rev Vaccines. 2008; 7(9):1357-65.
PMID: 18980539
PMC: 2680498.
DOI: 10.1586/14760584.7.9.1357.
Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies.
Parthasarathy N, DeShazer D, England M, Waag D
Diagn Microbiol Infect Dis. 2006; 56(3):329-32.
PMID: 16765554
PMC: 7127370.
DOI: 10.1016/j.diagmicrobio.2006.04.018.